Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Bacfo Pharmaceuticals (India ) Limited, is an unlisted public company incorporated on 20 October, 1994. It is classified as a public limited company and is located in , Delhi. It's authorized share capital is INR 4.00 cr and the total paid-up capital is INR 2.61 cr.
Bacfo Pharmaceuticals (India ) Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's EBITDA has decreased by 13.51% over the previous year. At the same time, it's book networth has increased by 18.16%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Arun Kumar Chauhan
Shareholder
|
00241128 | 31 years |
| Director | Rajesh Puri
Shareholder
|
00355335 | 19 years |
| Director | Akhil Chauhan
Shareholder
|
01447201 | 19 years |
| Additional Director | Achal Kumar Chauhan
Shareholder
|
05356488 | 13 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 6
Total Amount : 26.8 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 0.3 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| I FINANCE COMPANY LIMITED |
Active
|
5.0 L | 3 | Delhi |
| ATHARV CARE INDIA PRIVATE LIMITED |
Active
|
1.0 L | 3 | Delhi |
| FIRST GRADE FORCE PRIVATE LIMITED |
Active
|
50.0 L | 1 | Delhi |
| BACFO & KRAUTER HOLDINGS PRIVATE LIMITED |
Active
|
1.7 Cr | 1 | Delhi |
| CINCORP INTERNATIONAL LIMITED |
Active
|
49.5 L | 3 | Delhi |
| CROBOLS-CROSS BORDER LEGAL SYSTEMS (INDIA) PRIVATE LIMITED |
Active
|
50.0 L | 1 | Delhi |
| TECHNICOM CHEMIE (INDIA) LIMITED |
Active
|
1.0 Cr | 1 | Delhi |
| KUNSTOCOM (INDIA) LIMITED |
Active
|
6.0 Cr | 1 | Delhi |
| THINKLITE INDIA PRIVATE LIMITED |
Active
|
5.0 L | 2 | Delhi |
Read more
The incorporation date of BACFO PHARMACEUTICALS (INDIA ) LIMITED is 20 October, 1994
The authorized share capital of BACFO PHARMACEUTICALS (INDIA ) LIMITED is INR ₹ 4.0 Cr.
The paid-up capital of BACFO PHARMACEUTICALS (INDIA ) LIMITED is INR ₹ 2.6 Cr.
The registered address of BACFO PHARMACEUTICALS (INDIA ) LIMITED is E-27, DEFENCE COLONY RING ROAD DEFENCE COLONY, NEW DELHI, Delhi, India, 110024 - 110024
The CIN number of BACFO PHARMACEUTICALS (INDIA ) LIMITED is U74899DL1994PLC062272.